14
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Thyrotropin Stimulates Specifically the Expression of the Autoantibody Binding Domains of the Thyroperoxidase Molecule

, , , , &
Pages 323-331 | Received 23 May 1998, Accepted 09 Oct 1998, Published online: 07 Jul 2009

References

  • Aaen K., Rygaard J., Josefsen K., Petersen H., Brogren C.-H., Horn T., Buschard K. Dependence of antigen expression on functional state of the cells. Diabetes 1990; 39: 697–701
  • Banga J. P, Barnett P. S, Ewins D. L, Page M. J., , McGregor A. M, et al. Mapping of autoantigenic epitopes on recombinant thyroid peroxidase fragments using polymerase chain reaction. Autoimmunity 1990; 6: 257–268
  • Banga J. P, Tomlinson R. W.S., Doble N., Odell E., McGregor A. M. Thyroid microsomal/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidasehorseradish peroxidase. Immunol. 1989; 67: 197–204
  • Buschard K., Brogren C-H., Ropke C., Rygaard J. Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific. BB rat monoclonal autoantibody IC2. APMIS. 1988; 96: 342–346
  • Chiovato L., Vitti P., Cucchi P., Mammoli C., Carayon P., Pinchera A. The expression of the microsomal/peroxidase autoantigen in human thyroid cells is thyrotropin dependent. Clin. Exp. Immunol. 1989; 76: 47–53
  • Czarnocka B., Janota-Bzowski M., McIntosh R. S, Ashgar P. F, Watson P. F, Kemp H., Carayon P., Weetman A. P. Immunoglobulin GK antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope-mapping analysis. J. Clin. Endocrinol. Metab. 1997; 82: 2639–2644
  • Czarnocka B., Ruf J., Ferrand M., Carayon P. Immunochemical properties of hTPO. ThyroperoxidaseThyroid Autoimmunity, P. Carayon, J. Colloque Ruf. INSERM/John Lebbey Eurotext. 1990; Vol. 207: 59–67
  • Dai C., Levy O., Carrasco N. Cloningcharacterization of the thyroid iodide transporter. Nature 1996; 379: 458–460
  • Doble N. D, Banga J. P, Pope R., Lalor E., Kilduff P., McGregor A. M. Autoantibodies to the thyroid microsomal/ thyroid peroxidase antigen are polyclonaldirected to several distinct antigenic sites. Immunol. 1988; 64: 23–29
  • Edmonds C. J., , Teller M, et al. Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose. Eur. J. Endocrin. 1994; 131: 120–124
  • Elisei R., Mariotti S., Swillens S., Vassart G., Ludgate M. Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroidthe gastric parietal cell. Autoimmunity 1990; 8: 65–70
  • Finke R., Seto P., Rapoport B. Evidence for the highly conformational nature of the epitope(s) on human thyroid peroxidase that are recognized by sera from patients with Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 1990; 71: 53–59
  • Hames B. D. Gel Electrophoresis of Proteins: A Practical Approach, B. D. Hames, D. Rickwood. IRL Press Ltd, London, Washington, DC 1981; 6–92
  • Hashizume K., Ichikawa K., Sakurai A., Suzuki S., Takeda M., Kobayashi M., Miydinoto T., Arai M., Nagasawa T. Administration of thyroxine in treated Graves' disease-effects on the level of antibodies to thyroid-stimulating hormone receptorson the risk of recurrence of hyperthyroidism. N. Engl. J. Med. 1991; 324: 947–953
  • Kämpe O., Anderson A., Björk E., Hallberg A., Karlsson F. A. High-glucose stimulation of 64.000-Mr islet cell autoantigen expression. Diabetes 1989; 38: 1326–1328
  • Laver W. G, Air G. M, Webster R. G., Smith-Gill S. J. Epitopes on protein antigenes: misconceptionsrealities. Cell 1990; 61: 553–556
  • Lucas A., Salinas I., Rius F., Pizarro E., Granada M. L, Foz M., Sanmarti A. Medical therapy of Graves' disease: Does thyroxine prevent recurrence of hyperthyroidism?. J. Clin. Endocrinol. Metab. 1997; 82: 2410–2413
  • Ludgate M., Mariotti S., Libert F., Dinsart C., Piccolo P., Santini P., Ruf J., Pinchera A., Vassart C. Antibodies to human thyroid peroxidase in autoimmune thyroid disease: studies with a cloned recombinant complementary deoxyribonucleic acid epitope. J. Clin. Endocrino. Metab. 1989; 68: 1091–1096
  • McIver B., Rae G., Wilkinson E., Gold A., Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroid-ism who are treated with an antithyroid drug. N. Engl. J. Med. 1996; 334: 220–224
  • McLachlan S. M., Rapoport B. The molecular biology of thyroid peroxidase: cloning, expressionrole as autoantigen in autoimmune thyroid disease. Endocr. Rev. 1992; 13: 192–203
  • Morris J. C, Bergert E. R, Bryant W. P. Binding of Immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid 1997; 7: 527–534
  • Maastricht J., Koenig R. J, Kaplan M. M, Arscott P., Thompson N., Baker J. R., Jr. Identification of localized autoantibody epitopes in thyroid peroxidase. J. Clin. Endocrinol. Metab. 1994; 79: 1648–1654
  • Rasmussen A. K, Kayser L., Perrild H., Brandt M., Bech K., Feldt-Rasmussen U. Human thyroid epithelial cells cultured in monolayers. I. Decreased thyroglobulinCAMP response to TSH in 12 weeks old secondarytertiary cultures. Mol. Cell. Endocrinol. 1996; 116: 165–172
  • Reinwein D., Benker G., Lazarus J. H., , Alexander W. D, et al. The European multicenter group on antithyroid drug treatment. A Prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J. Clin. Endocrinol. Metab. 1993; 76: 1516–1521
  • Ruf J., Toubert M. E, Czarnocka B., Durand-Gorde J. M, Ferrand M., Carayon P. Relationship between immunological structurebiochemical properties of human thyroid peroxidase. Endocrinol. 1989; 125: 1211–1218
  • Seto P., Hirayu H., Magnusson R. P, Gestautas J., Portmann L., DeGroot L. J., , Rapoport B, et al. Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the Gene for thyroid peroxidase. J. Clin. Invest. 1987; 80: 1205–1208
  • SzabóoA J., Trieb K., Gratzl R., Sztankay A., Grubeck-Loebenstein B. The effect of TSHTSI on the thyroglobulin expression of cultured human thyroid cells. Acta Med. Hung. 1992/93; 49: 225–231
  • Tamai H., Hayaki I., Kawai K., Komaki G., Matsubayashi K., Kuma K., Kumagai L. F., , Nagataki S, et al. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated stimulating hormone receptor antibody levels in treated Graves' disease patients. J. Clin. Endocrinol. Metab. 1995; 80: 1481–1484
  • Tonacchera M., Cetani F., Costagliola S., Alcalde L., Uibo G., Vassart G., Ludgate M. Mapping thyroid peroxidase epitopes using recombinant protein fragments. Europ. J. Endocrinol. 1995; 132: 53–61
  • Van Thiel ThPH., Van der Linden J. C, Baak J. P.A., Van de Sandt M. M, Van Galen C., Bezemer P. D. Reproducibility of flow cytometric assessment of follicular tumours of the thyroid. J. Clin. Pathol. 1989; 42: 260–263
  • Weetman A. P., , McGregor A. M, et al. Autoimmune thyroid disease: Further developments in our understanding. Endocr. Rev. 1994; 15: 788–830

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.